Propofol

This classification denotes a sedative and hypnotic with the molecular formula C12H18O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YI7VU623SF, chemically known as 2,6-dipropan-2-ylphenol but generally known as propofol, which bears US NIH Compound Identifier 4943. European Medicines Agency schedules Propofol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10116MIG. The term PROPOFOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules propofol in its Anatomical Therapeutic Chemical (ATC) Classification. PROPOFOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule propofol under HS 29071990 and SITC 51243. As of Q4 2014, PROPOFOL remains the US FDA Preferred Term for this commodity. Propofol bears US NLM identifiers UMLS ID C0033487 and NCI Concept Code C29384. SMILES: CC(C)C1=C(C(=CC=C1)C(C)C)O.